Obesity, inflammation, and insulin resistance

White adipose tissue (WAT) is considered an endocrine organ. When present in excess, WAT can influence metabolism via biologically active molecules. Following unregulated production of such molecules, adipose tissue dysfunction results, contributing to complications associated with obesity. Previous studies have implicated pro- and anti-inflammatory substances in the regulation of inflammatory response and in the development of insulin resistance. In obese individuals, pro-inflammatory molecules produced by adipose tissue contribute to the development of insulin resistance and increased risk of cardiovascular disease. On the other hand, the molecules with anti-inflammatory action, that have been associated with the improvement of insulin sensitivity, have your decreased production. Imbalance of these substances contributes significantly to metabolic disorders found in obese individuals. The current review aims to provide updated information regarding the activity of biomolecules produced by WAT

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. Methods: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. Findings: Global DALYs increased from 2·63 billion (95% UI 2·44–2·85) in 2010 to 2·88 billion (2·64–3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7–17·3) between 2010 and 2019. Notably, however, this decrease in rates reversed during the first 2 years of the COVID-19 pandemic, with increases in global age-standardised all-cause DALY rates since 2019 of 4·1% (1·8–6·3) in 2020 and 7·2% (4·7–10·0) in 2021. In 2021, COVID-19 was the leading cause of DALYs globally (212·0 million [198·0–234·5] DALYs), followed by ischaemic heart disease (188·3 million [176·7–198·3]), neonatal disorders (186·3 million [162·3–214·9]), and stroke (160·4 million [148·0–171·7]). However, notable health gains were seen among other leading communicable, maternal, neonatal, and nutritional (CMNN) diseases. Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3–51·7) and for diarrhoeal diseases decreased by 47·0% (39·9–52·9). Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). Between 2010 and 2021, among the 25 leading Level 3 causes, age-standardised DALY rates increased most substantially for anxiety disorders (16·7% [14·0–19·8]), depressive disorders (16·4% [11·9–21·3]), and diabetes (14·0% [10·0–17·4]). Age-standardised DALY rates due to injuries decreased globally by 24·0% (20·7–27·2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61·3 years (58·6–63·6) in 2010 to 62·2 years (59·4–64·7) in 2021. However, despite this overall increase, HALE decreased by 2·2% (1·6–2·9) between 2019 and 2021. Interpretation: Putting the COVID-19 pandemic in the context of a mutually exclusive and collectively exhaustive list of causes of health loss is crucial to understanding its impact and ensuring that health funding and policy address needs at both local and global levels through cost-effective and evidence-based interventions. A global epidemiological transition remains underway. Our findings suggest that prioritising non-communicable disease prevention and treatment policies, as well as strengthening health systems, continues to be crucially important. The progress on reducing the burden of CMNN diseases must not stall; although global trends are improving, the burden of CMNN diseases remains unacceptably high. Evidence-based interventions will help save the lives of young children and mothers and improve the overall health and economic conditions of societies across the world. Governments and multilateral organisations should prioritise pandemic preparedness planning alongside efforts to reduce the burden of diseases and injuries that will strain resources in the coming decades. Funding: Bill & Melinda Gates Foundation

Protective Effects of Polyphenol Ex-tracts from Sea Buckthorn (Hippophaė rhamnoides L.) on Rat Hearts

Abstract The objective of present study was to investigate the antioxidative and cardioprotective effects of polyphenol extracts from sea buckthorn (PESB) against myocardial ischemia reperfusion injury (MIRI). PESB was analyzed using HPLC-DAD and their antioxidant activities were evaluated by measuring the intrinsic free radicals cavenging capacity and inhibiting the formation of hydroxyl radical capacity. Experiments on the isolated rat hearts were carried out according to the improved Langendorff retrograde perfusion technology. Coronary effluent of lactate dehydrogenase (LDH) and creatine kinase isoenzyme (CK-MB) activities were analyzed to determine the extent of myocardial injury. Protein expression levels of Beclin-1, microtubule-associated protein 1 light chain 3 (LC3) I and II were measured to evaluate the degree of autophagy. In conclusion, coupled results from both in vivo and in vitro experiments have confirmed that PESB has potential health implications in both prevention and amelioration of MIRI, which may be attributed to the inhibition of autophagy

Deep view of Composite SNR CTA1 with LHAASO in γ\gamma-rays up to 300 TeV

International audienceThe ultra-high-energy (UHE) gamma-ray source 1LHAASO J0007+7303u is positionally associated with the composite SNR CTA1 that is located at high Galactic Latitude $b\approx 10.5^\circ$. This provides a rare opportunity to spatially resolve the component of the pulsar wind nebula (PWN) and supernova remnant (SNR) at UHE. This paper conducted a dedicated data analysis of 1LHAASO J0007+7303u using the data collected from December 2019 to July 2023. This source is well detected with significances of 21$\sigma$ and 17$\sigma$ at 8$-$100 TeV and $>$100 TeV, respectively. The corresponding extensions are determined to be 0.23$^{\circ}\pm$0.03$^{\circ}$ and 0.17$^{\circ}\pm$0.03$^{\circ}$. The emission is proposed to originate from the relativistic electrons and positrons accelerated within the PWN of PSR J0007+7303. The energy spectrum is well described by a power-law with an exponential cutoff function $dN/dE = (42.4\pm4.1)(\frac{E}{20\rm\ TeV})^{-2.31\pm0.11}\exp(-\frac{E}{110\pm25\rm\ TeV})$$\rm\ TeV^{-1}\ cm^{-2}\ s^{-1}$in the energy range from 8 TeV to 300 TeV, implying a steady-state parent electron spectrum $dN_e/dE_e\propto (\frac{E_e}{100\rm\ TeV})^{-3.13\pm0.16}\exp[(\frac{-E_e}{373\pm70\rm\ TeV})^2]$ at energies above $\approx 50 \rm\ TeV$. The cutoff energy of the electron spectrum is roughly equal to the expected current maximum energy of particles accelerated at the PWN terminal shock. Combining the X-ray and gamma-ray emission, the current space-averaged magnetic field can be limited to $\approx 4.5\rm\ \mu G$. To satisfy the multi-wavelength spectrum and the $\gamma$-ray extensions, the transport of relativistic particles within the PWN is likely dominated by the advection process under the free-expansion phase assumption

Deep view of Composite SNR CTA1 with LHAASO in γ\gamma-rays up to 300 TeV

International audienceThe ultra-high-energy (UHE) gamma-ray source 1LHAASO J0007+7303u is positionally associated with the composite SNR CTA1 that is located at high Galactic Latitude $b\approx 10.5^\circ$. This provides a rare opportunity to spatially resolve the component of the pulsar wind nebula (PWN) and supernova remnant (SNR) at UHE. This paper conducted a dedicated data analysis of 1LHAASO J0007+7303u using the data collected from December 2019 to July 2023. This source is well detected with significances of 21$\sigma$ and 17$\sigma$ at 8$-$100 TeV and $>$100 TeV, respectively. The corresponding extensions are determined to be 0.23$^{\circ}\pm$0.03$^{\circ}$ and 0.17$^{\circ}\pm$0.03$^{\circ}$. The emission is proposed to originate from the relativistic electrons and positrons accelerated within the PWN of PSR J0007+7303. The energy spectrum is well described by a power-law with an exponential cutoff function $dN/dE = (42.4\pm4.1)(\frac{E}{20\rm\ TeV})^{-2.31\pm0.11}\exp(-\frac{E}{110\pm25\rm\ TeV})$$\rm\ TeV^{-1}\ cm^{-2}\ s^{-1}$in the energy range from 8 TeV to 300 TeV, implying a steady-state parent electron spectrum $dN_e/dE_e\propto (\frac{E_e}{100\rm\ TeV})^{-3.13\pm0.16}\exp[(\frac{-E_e}{373\pm70\rm\ TeV})^2]$ at energies above $\approx 50 \rm\ TeV$. The cutoff energy of the electron spectrum is roughly equal to the expected current maximum energy of particles accelerated at the PWN terminal shock. Combining the X-ray and gamma-ray emission, the current space-averaged magnetic field can be limited to $\approx 4.5\rm\ \mu G$. To satisfy the multi-wavelength spectrum and the $\gamma$-ray extensions, the transport of relativistic particles within the PWN is likely dominated by the advection process under the free-expansion phase assumption

Data quality control system and long-term performance monitor of the LHAASO-KM2A

International audienceThe KM2A is the largest sub-array of the Large High Altitude Air Shower Observatory (LHAASO). It consists of 5216 electromagnetic particle detectors (EDs) and 1188 muon detectors (MDs). The data recorded by the EDs and MDs are used to reconstruct primary information of cosmic ray and gamma-ray showers. This information is used for physical analysis in gamma-ray astronomy and cosmic ray physics. To ensure the reliability of the LHAASO-KM2A data, a three-level quality control system has been established. It is used to monitor the status of detector units, stability of reconstructed parameters and the performance of the array based on observations of the Crab Nebula and Moon shadow. This paper will introduce the control system and its application on the LHAASO-KM2A data collected from August 2021 to July 2023. During this period, the pointing and angular resolution of the array were stable. From the observations of the Moon shadow and Crab Nebula, the results achieved using the two methods are consistent with each other. According to the observation of the Crab Nebula at energies from 25 TeV to 100 TeV, the time averaged pointing errors are estimated to be $-0.003^{\circ} \pm 0.005^{\circ}$ and $0.001^{\circ} \pm 0.006^{\circ}$ in the R.A. and Dec directions, respectively

An Ultrahigh-energy γ\gamma-ray Bubble Powered by a Super PeVatron

International audienceWe report the detection of a $\gamma$-ray bubble spanning at least 100$\rm deg^2$ in ultra high energy (UHE) up to a few PeV in the direction of the star-forming region Cygnus X, implying the presence Super PeVatron(s) accelerating protons to at least 10 PeV. A log-parabola form with the photon index $\Gamma (E) = (2.71 \pm 0.02) + (0.11 \pm 0.02) \times \log_{10} (E/10 \ {\rm TeV})$ is found fitting the gamma-ray energy spectrum of the bubble well. UHE sources, `hot spots' correlated with very massive molecular clouds, and a quasi-spherical amorphous $\gamma$-ray emitter with a sharp central brightening are observed in the bubble. In the core of $\sim 0.5^{\circ}$, spatially associating with a region containing massive OB association (Cygnus OB2) and a microquasar (Cygnus X-3), as well as previously reported multi-TeV sources, an enhanced concentration of UHE $\gamma$-rays are observed with 2 photons at energies above 1 PeV. The general feature of the bubble, the morphology and the energy spectrum, are reasonably reproduced by the assumption of a particle accelerator in the core, continuously injecting protons into the ambient medium